Patient Square Capital will acquire SOC Telemed, the acute care telehealth company announced Thursday.
SOC Telemed—formerly known as Specialists On Call—went public in 2020 by merging with a special purpose acquisition company in 2020.
SOC Telemed will again be privately held once Patient Square Capital completes its purchase. The vendor offers technology and services for such specialty care as neurology, critical care and pulmonology to hospitals, physician networks and other healthcare organizations. SOC Telemed expects the deal to close in the second quarter.
Shareholders will receive $3 in cash per share of common stock, representing a premium of 366.1% over SOC Telemed's closing share price on Wednesday and 93.1% over the company's 60-day volume-weighted average price through Wednesday, according to a news release. Shares closed at $2.85 Thursday, up from $0.64 on Wednesday.
"We believe that as a private company, with the expertise and support of the team at Patient Square Capital, SOC Telemed will be best positioned to meet the growing needs of patients, physicians and our hospital partners," Dr. Chris Gallagher, the company's CEO said in a news release.
Download Modern Healthcare’s app to stay informed when industry news breaks.